Ad Clicks : Ad Views : Ad Clicks : Ad Views : Ad Clicks : Ad Views : Ad Clicks : Ad Views : Ad Clicks : Ad Views : Ad Clicks : Ad Views : Ad Clicks : Ad Views : Ad Clicks : Ad Views : Ad Clicks : Ad Views : Ad Clicks : Ad Views : Ad Clicks : Ad Views : Ad Clicks : Ad Views : Ad Clicks : Ad Views : Ad Clicks : Ad Views : Ad Clicks : Ad Views : Ad Clicks : Ad Views : Ad Clicks : Ad Views :

NIH Study Reveals Glaucoma Drug that Can Resolve Blinding Disorder

/
/
/
79 Views


Obesity remains one of the biggest health concerns in the United States, but as per the new study funded by the National Institutes of Health an inexpensive glaucoma drug that is designed to control obesity can resolve blinding disorderas well. The new report by NIH claims that the new glaucoma drug can improve the vision for women with a disorder called idiopathic intracranial hypertension also known as IIH. The study also mentioned that more than 100,000 American women have made use of the IIH and the number is rising with obesity epidemic that is spreading across the United States.

nei 23 l
Source by : nih.gov

The trial was funded by NIH’s National Eye Institute and was coordinated by the Neuro-Ophthalmology Research Disease Investigator Consortium. The results were published in the Journal of the American Medical Association. According to the report acetazolamide can help and preserve and even restore vision for women with IIH when combined with moderate but comprehensive dietary and lifestyle modification plan. Acetazolamide is best known as a glaucoma drug and has been used in many different medications related to eye disorders. The report also claims that they have tried the medication in their study and they have seen improvements in both groups, one with the drug and one without. However, they saw greatest improvements in the group that received the drugs. On the other hand, all the patients were allowed to take headache medications along with the drug and there were no side effects or any other health problems that were seen. The trial included more than 161 women and four men with IIH and mild vision loss.

Newsletter

Get our Tips and Tricks to your Inbox

This div height required for enabling the sticky sidebar